Cancer Cytopathology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.9 | Q2 | 67.8% | 0.983 | Q2 | 83.5% |
| 2024 | 3.2 | Q2 | 75.6% | 1.220 | Q2 | 88.7% |
| 2023 | 2.6 | Q2 | 59.0% | 0.991 | Q2 | 85.3% |
| 2022 | 3.4 | Q2 | 66.2% | 1.231 | Q1 | 90.4% |
| 2021 | 4.3 | Q2 | 69.7% | 1.133 | Q2 | 89.0% |
| 2020 | — | — | 1.290 | Q2 | 90.1% | |
| 2019 | — | — | 1.365 | Q1 | 91.3% | |
| 2018 | — | — | 1.571 | Q1 | 92.5% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1934-6638
ISSN
1934-662X
country
UScoverage
2008-2026